Immune complex isolation

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/37

G01N 33/53 (2006.01) G01N 33/564 (2006.01) G01N 33/566 (2006.01)

Patent

CA 1233115

ABSTRACT OF THE DISCLOSURE To diagnose diseases in patients, a protein com- plex, RhC, is prepared from horse serum by precipi- tating a white powder from the serum at a pH of 5.5 and processing to remove lipids at: a pH of 8.2 using Tris-HCl as the buffer. It includes two components bound together to provide a molecular weight of 280,000 and having characteristics of a rheumatoid factor and a Clq-like subcomponent of the complement. The protein complex is incubated with human serum or plasma and then precipitated by dialysis against a high pH buffer (.05 M Tris-HCl pH 8.2). When precipitated, it co- precipitates the immune complexes from the human blood serum without substantial monomeric immunoglobulin to quantitatively isolate immune complexes from serum. Immunological assays then determine how much immune complex and what kind were in the serum.

440703

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immune complex isolation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immune complex isolation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune complex isolation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1275133

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.